about
Controlling dengue with vaccines in ThailandEstimating influenza vaccine efficacy from challenge and community-based study dataThe epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016Projected spread of Zika virus in the AmericasThe dengue vaccine pipeline: Implications for the future of dengue controlThe case for a typhoid vaccine probe study and overview of design elementsThe global transmission and control of influenzaThe First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic InfectionPersistent infection of macaques with simian-human immunodeficiency virusesGenome sequencing reveals Zika virus diversity and spread in the AmericasSpread of Zika virus in the AmericasZika virus evolution and spread in the Americas.FluTE, a publicly available stochastic influenza epidemic simulation modelContaining pandemic influenza with antiviral agents.Strategy for distribution of influenza vaccine to high-risk groups and children.Finding optimal vaccination strategies for pandemic influenza using genetic algorithms.Containing pandemic influenza at the source.Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004Detecting human-to-human transmission of avian influenza A (H5N1).Modeling targeted layered containment of an influenza pandemic in the United States.Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model.Seven challenges for model-driven data collection in experimental and observational studies.A Bayesian model for evaluating influenza antiviral efficacy in household studies with asymptomatic infectionsStrategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.The transmissibility and control of pandemic influenza A (H1N1) virus.One versus two doses: What is the best use of vaccine in an influenza pandemic?Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies.School opening dates predict pandemic influenza A(H1N1) outbreaks in the United StatesThe effect of age on transmission of 2009 pandemic influenza A (H1N1) in a camp and associated householdsPlanning for the control of pandemic influenza A (H1N1) in Los Angeles County and the United StatesPerformance of rapid influenza H1N1 diagnostic tests: a meta-analysisOptimal vaccine allocation for the early mitigation of pandemic influenza.Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.Ebola: mobility data.Estimating vaccine efficacy using auxiliary outcome data and a small validation sample.Invited commentary: Challenges of using contact data to understand acute respiratory disease transmission.A Data-Augmentation Method for Infectious Disease Incidence Data from Close Contact GroupsInvited commentary: Evaluating vaccination programs using genetic sequence data.Changes in human immunodeficiency virus type 1 envelope glycoproteins responsible for the pathogenicity of a multiply passaged simian-human immunodeficiency virus (SHIV-HXBc2)
P50
Q21562250-686ED79B-B28D-4EFB-9454-A645BF09BE13Q24655781-6CFEDCAB-E972-4C63-B5C6-E06D6520D03CQ26247279-8375850E-2046-4F72-8987-5FB2D7F149DAQ26252071-F850ECAE-9837-4812-B387-48F41FEF8F23Q26314683-7D159F9F-A82D-4510-81C4-23AAB19B855AQ26859432-3107C0A4-DB73-4463-AEA3-B4201DD83EB5Q27342983-108212E5-3278-4C81-920A-1EF8F56063E4Q27928053-63F41235-EC49-4434-B442-DAE49B055C41Q28393073-1EB17ACC-5BA5-4D18-8D37-16C8E1632AABQ28775731-AA1ACEF6-EC6F-4BBE-880F-B958D925C280Q28803990-219EF83E-4B5A-4C5B-9CCA-62392DD1DDB2Q29587277-F37A4CB9-689A-43EC-9457-F79729613A44Q30145571-464634F1-32F1-445B-A23F-60799BBC5697Q30227314-6218CE3F-594A-46A7-B3CD-822604BF456CQ30340951-A265D6AC-2008-49A7-9898-8048210B7BC5Q30350117-D4B8687B-0CFE-49DE-B576-F4F7614EB91DQ30350344-502465C2-5D34-47C4-902F-D94E037D7252Q30351179-E1713DE3-F076-4FD9-B05E-B40115139EFDQ30360764-41F91C40-B374-47B4-8829-99167257C231Q30367596-EBFC92F1-E004-463E-803C-D918E88BF477Q30368183-605A4557-25DB-4606-8447-1C86F0369906Q30371134-1923C29E-4CB7-41CA-8EED-C355B2D6F4A6Q30373408-62238E3F-522D-4762-88C7-29D475F23D09Q30374811-EDC87E4A-8799-4525-BBE6-F02C4969DEAFQ30379858-CFACEE88-B7F0-4250-A388-FEDBD140489BQ30380569-57C21C11-DE0D-497A-86EA-7A269E822A35Q30382026-509B042F-A88A-49C0-AFBD-E4642DEC8D2EQ30388996-E730565B-EFA8-4AFA-A84B-6718889B0BD7Q30392554-B78CF3B3-F656-49E2-A44F-61537DBE0355Q30398568-DAA9D035-1EB0-454A-88AD-BDC1950E1016Q30401049-0BEADFAD-AD74-4C4E-8CE7-C4706ACB0998Q30406611-CC26BB88-D37D-46A4-B35C-B2BF2B8CBBA5Q30428994-192EEA94-242A-4823-A520-F3A9795EE168Q30499938-99DDB862-462D-43BD-A6F8-268D95BE5582Q30863896-D9633EB1-A6DE-4C31-BB21-CE1443760368Q30952584-58FC3890-837A-476D-9428-FB2E252A3676Q31060639-7C4B92BE-1578-4B09-B97A-56C060B50510Q31171693-BD66328E-1886-4C02-A876-F2B5A5547327Q33515874-FE41746A-3DBC-4096-992A-5E0A6957584CQ33640139-FCA70207-E4B4-495A-84F4-76C8E85FB098